Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 2/3 1

Status

Completed 33Active not recruiting 8Terminated 6Unknown 4Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 51NETWORK 9NIH 7INDUSTRY 6

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Thoracic 2Dermatologic 1CNS 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Skin Neoplasms 1Pleural Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Glioblastoma 1Fibroadenoma 1Dyschromatosis symmetrica hereditaria 1 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 183Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 53fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 39Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Surgical Procedures, Operative × Clear all
NCT06295809 2026-05-08

INTerpath-007

Merck Sharp & Dohme LLC

Phase 2/3 Terminated
46 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

NCT04770272 2026-01-12

neoMono

Palleos Healthcare GmbH

Phase 2 Terminated
442 enrolled 42 charts
Breast

Triple Negative Breast Neoplasms

NCT00840749 2020-07-14

STARS

Accuray Incorporated

Phase NA Terminated
36 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03742401 2020-03-16

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)

Theraclion

Phase NA Terminated
2 enrolled

Fibroadenoma

NCT00316134 2011-11-08

Multiple Biomarkers in Undiagnosed Pleural Effusion

Fujirebio Diagnostics, Inc.

Terminated
200 enrolled
Thoracic

Pleural Diseases, Pleural Effusion, Pleural Neoplasms, Pleural Effusion, Malignant

NCT00515086 2011-09-22

Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)

Novartis

Phase 2 Terminated
41 enrolled 11 charts
CNS

Dyschromatosis symmetrica hereditaria 1, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡